PDS Biotechnology Corporation (PDSB) NASDAQ
0.63
-0.023(-3.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.63
-0.023(-3.52%)
Currency In USD
| Market Cap | 59.42M |
| Enterprise Value | 39.56M |
| P/E Ratio | -0.85 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.13 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.86 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.01 |
| Return On Equity | -2.09 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -59,791 |
| EBITDA | -33.75M |
| Net Income | -37.61M |
| Diluted EPS | -1.03 |
| Total Cash | 26.2M |
| Total Cash/Share | 0.56 |
| Total Debt | 17.97M |
| Total Debt/Equity | 1.9 |
| Current Ratio | 2.09 |
| Book Value Per Share | 0.2 |
| 52-Week Change | -48.7 |
| 52-Week High | 1.92 |
| 52-Week Low | 0.6 |
| Moving Average 50 Days | 0.79 |
| Moving Average 200 Days | 1.04 |
| Average Volume | 579,151 |
| Shares Outstanding | 54.72M |
| % Held by Institutions | 16.81 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 18, 2019 |